Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04542616
Status:
RECRUITING
Last Update Posted:
2023-10-12
First Post:
2020-08-27
Brief Title:
Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma
Sponsor:
State University of New York at Buffalo
Organization:
State University of New York at Buffalo
Organization Data
Organization:
State University of New York at Buffalo
Class:
OTHER
Study ID:
STUDY00004680
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
State University of New York at Buffalo
Lead Sponsor Class:
OTHER
Responsible Party:
Asher Weiner MD
Responsible Party Title:
Clinical Associate Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
State University of New York at Buffalo
Old Name:
None
Old Organization:
None